Somatic mutations of the JAK/STAT3 pathway have been found to be major drivers of many tumors derived from inflammatory conditions, as well as in systemic and cutaneous forms of ALCL [34,35]. Here, STAT3 is linked to anaplastic large cell lymphoma.